Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas

NCT05479123 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

52

Enrollment

OTHER

Sponsor class

Stopped due to lack of recruitment and follow up compliance

Conditions

Infantile Hemangioma

Interventions

DRUG: Propranolol three times a day
DRUG: Propranolol twice a day
DRUG: Timolol

Sponsor

The University of Texas Health Science Center, Houston